| Inadequate control of heart rate in patients with stable angina: results from the European heart survey. | |
MedLine Citation:
|
PMID: 20354044 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: To examine resting heart rate (HR) in a population presenting with stable angina in relation to prior and subsequent pharmacological treatment, comorbid conditions and clinical outcome. METHODS AND RESULTS: The European Heart Survey was a prospective, observational, cohort study of 3779 patients with stable angina newly presenting to cardiology services. Mean baseline resting HR was 73 beats/min (bpm) and 52.3% of patients had a baseline HR > 70 bpm. Over half of patients were on no chronotropic medication at baseline. Patients with chronic respiratory disease or diabetes had higher resting HRs (75-76 bpm), and were more likely to have been receiving calcium channel blockers at baseline assessment. Overall, beta-blockers were the most common treatment administered following cardiologist assessment, but were used less frequently in patients with chronic respiratory disease and diabetes, and the dosages used were less than that found to be effective in clinical trials. Mean daily doses of metoprolol, bisoprolol, carvedilol, and atenolol were 75 mg, 6 mg, 19 mg and 55 mg, respectively. Higher HR at baseline was associated with higher rates of cardiovascular mortality and hospitalisation for heart failure. CONCLUSION: Control of ischaemic symptoms through heart rate modification in patients with angina is currently inadequate, both by primary referring physicians and cardiologists. Given the adverse outcome associated with higher resting heart rates in this as in other studies, and the availability of specific HR reducing strategies, attention should be given to achieving optimal HR control. |
Authors:
|
Caroline A Daly; Felicity Clemens; Jose L Lopez Sendon; Luigi Tavazzi; Eric Boersma; Nicolas Danchin; François Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox; |
Related Documents
:
|
6462564 - Fetal heart rate pattern and postparacervical fetal bradycardia. 11885884 - Cardiovascular involvement in hiv/aids: report of 3 cases. 17946464 - Further study of the asymmetry for multifractal spectra of heartbeat time series. 21830104 - Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis ... 20805834 - Is the outcome in acute spinal cord ischaemia different from that in traumatic spinal c... 8187974 - Gastric endoscopic features in patients with liver cirrhosis: correlation with esophage... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Postgraduate medical journal Volume: 86 ISSN: 1469-0756 ISO Abbreviation: Postgrad Med J Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-03-31 Completed Date: 2010-10-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0234135 Medline TA: Postgrad Med J Country: England |
Other Details:
|
Languages: eng Pagination: 212-7 Citation Subset: IM |
Affiliation:
|
St James's Hospital, Dublin 8, Ireland. cadaly@stjames.ie |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Angina Pectoris / complications, drug therapy, physiopathology* Anti-Arrhythmia Agents / therapeutic use* Arrhythmias, Cardiac / complications, drug therapy* Diabetes Complications / complications Female Heart Rate* / physiology Humans Hypertension / complications Male Middle Aged Prospective Studies Pulmonary Disease, Chronic Obstructive / complications Risk Factors Vascular Diseases / complications |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment...
Next Document: Imaging evaluation of demyelinating processes of the central nervous system.